Bio-Techne Aktie
WKN DE: A12ENG / ISIN: US09073M1045
|
05.02.2025 12:38:46
|
Bio-Techne Corp. Q2 Profit Increases, Beats Estimates
(RTTNews) - Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates.
The company's bottom line totaled $34.89 million, or $0.22 per share. This compares with $27.47 million, or $0.17 per share, last year.
Excluding items, Bio-Techne Corp. reported adjusted earnings of $68.13 million or $0.42 per share for the period.
Analysts on average had expected the company to earn $0.38 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 9.0% to $297.03 million from $272.60 million last year.
Bio-Techne Corp. earnings at a glance (GAAP) :
-Earnings: $34.89 Mln. vs. $27.47 Mln. last year. -EPS: $0.22 vs. $0.17 last year. -Revenue: $297.03 Mln vs. $272.60 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bio-Techne Corpmehr Nachrichten
Analysen zu Bio-Techne Corpmehr Analysen
Aktien in diesem Artikel
| Bio-Techne Corp | 51,00 | 2,00% |
|